Explore more with Alida Biosciences’ resources

Arabidopsis wild type and clock-gene knockouts (EpiScout v1.3) Healthy Human Brain (EpiScout v1.3) RNA Modification Writer Perturbation (EpiScout v2.3) Healthy Mouse Cardiac Tissue (EpiScout v1.3)

RNA Input Requirements for Optimal Assay Performance More Reads, More Leads? Understanding the Impact of Sequencing Depth on RNA Modification Detection EpiPlex® Platform Delivers High-quality RNA-Seq and More Benchmarking the EpiPlex Assay Against MeRIP for m6A Mapping Engineered Protein Binders for RNA Modification Capture Integration of Pseudouridine Detection into the EpiPlex® Platform

EpiPlex Platform for Epitranscriptomics EpiScout Analysis Software

A Subset Analysis of Clinical Activity and Pharmacodynamic Biomarkers in Patients with Sarcomas in the Phase 1 Dose Escalation Study of STC-15, a METTL3 Inhibitor Dysregulation of the RNA modification m6A promotes cancer progression and provides therapeutic opportunities Direct RNA Sequencing reveals epitranscriptomic regulation of brain cells and Alzheimer’s Disease pathology N6-methyladenosine RNA methylation is a novel epitranscriptomic regulator of excessive alcohol drinking and vulnerability to relapse Epitranscriptome-wide profiling identifies RNA editing events regulated by ADAR1 that are associated with DNA repair Mapping multiple RNA modifications simultaneously by proximity barcode sequencing

EpiScout v1.3 User Guide Poly(A)-Enriched RNA Workflow Total RNA Workflow

EpiPlex Product Specifications EpiScout Product Specifications EpiPlex UDI Kit 24-UDI kit Plate Map and Indicies EpiPlex UDI Kit 96-UDI kit Plate Map and Indicies EpiPlex Reagent MSDS (Cat# 100108 & 100124)

Frequently asked questions